How to Support the Use of AI in Clinical Trials in France ?

Artificial intelligence (AI) could play a pivotal role in transforming clinical trials, a cornerstone for developing new treatments and medications. With the potential to improve recruitment, optimize complex data analysis, and reduce costs, AI represents a promising opportunity to accelerate these processes. France, with its rich ecosystem of health data, is well-positioned to harness this potential and promote the use of AI in implementing clinical trials. However, several challenges and obstacles need to be addressed.